278 related articles for article (PubMed ID: 11145714)
1. A deletion in the gene encoding the CD45 antigen in a patient with SCID.
Tchilian EZ; Wallace DL; Wells RS; Flower DR; Morgan G; Beverley PC
J Immunol; 2001 Jan; 166(2):1308-13. PubMed ID: 11145714
[TBL] [Abstract][Full Text] [Related]
2. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID).
Macchi P; Villa A; Giliani S; Sacco MG; Frattini A; Porta F; Ugazio AG; Johnston JA; Candotti F; O'Shea JJ
Nature; 1995 Sep; 377(6544):65-8. PubMed ID: 7659163
[TBL] [Abstract][Full Text] [Related]
3. New insights into the transmembrane protein tyrosine phosphatase CD45.
Sasaki T; Sasaki-Irie J; Penninger JM
Int J Biochem Cell Biol; 2001 Nov; 33(11):1041-6. PubMed ID: 11551820
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease.
Kung C; Pingel JT; Heikinheimo M; Klemola T; Varkila K; Yoo LI; Vuopala K; Poyhonen M; Uhari M; Rogers M; Speck SH; Chatila T; Thomas ML
Nat Med; 2000 Mar; 6(3):343-5. PubMed ID: 10700239
[TBL] [Abstract][Full Text] [Related]
5. Monocyte function in a severe combined immunodeficient patient with a donor splice site mutation in the Jak3 gene.
Villa A; Sironi M; Macchi P; Matteucci C; Notarangelo LD; Vezzoni P; Mantovani A
Blood; 1996 Aug; 88(3):817-23. PubMed ID: 8704236
[TBL] [Abstract][Full Text] [Related]
6. Atypical X-linked SCID phenotype associated with growth hormone hyporesponsiveness.
Ursini MV; Gaetaniello L; Ambrosio R; Matrecano E; Apicella AJ; Salerno MC; Pignata C
Clin Exp Immunol; 2002 Sep; 129(3):502-9. PubMed ID: 12197892
[TBL] [Abstract][Full Text] [Related]
7. X-linked SCID and other defects of cytokine pathways.
Uribe L; Weinberg KI
Semin Hematol; 1998 Oct; 35(4):299-309. PubMed ID: 9801259
[TBL] [Abstract][Full Text] [Related]
8. CD45-deficient severe combined immunodeficiency caused by uniparental disomy.
Roberts JL; Buckley RH; Luo B; Pei J; Lapidus A; Peri S; Wei Q; Shin J; Parrott RE; Dunbrack RL; Testa JR; Zhong XP; Wiest DL
Proc Natl Acad Sci U S A; 2012 Jun; 109(26):10456-61. PubMed ID: 22689986
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the calcium/NF-AT T cell activation pathway by the D2 domain of CD45.
Wang Y; Liang L; Esselman WJ
J Immunol; 2000 Mar; 164(5):2557-64. PubMed ID: 10679094
[TBL] [Abstract][Full Text] [Related]
10. The extracellular domain of CD45 controls association with the CD4-T cell receptor complex and the response to antigen-specific stimulation.
Leitenberg D; Novak TJ; Farber D; Smith BR; Bottomly K
J Exp Med; 1996 Jan; 183(1):249-59. PubMed ID: 8551228
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis mediated through CD45 is independent of its phosphatase activity and association with leukocyte phosphatase-associated phosphoprotein.
Fortin M; Steff AM; Felberg J; Ding I; Schraven B; Johnson P; Hugo P
J Immunol; 2002 Jun; 168(12):6084-9. PubMed ID: 12055218
[TBL] [Abstract][Full Text] [Related]
12. A CD45 minigene restores regulated isoform expression and immune function in CD45-deficient mice: therapeutic implications for human CD45-null severe combined immunodeficiency.
Virts EL; Diago O; Raschke WC
Blood; 2003 Feb; 101(3):849-55. PubMed ID: 12393487
[TBL] [Abstract][Full Text] [Related]
13. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency.
Puel A; Ziegler SF; Buckley RH; Leonard WJ
Nat Genet; 1998 Dec; 20(4):394-7. PubMed ID: 9843216
[TBL] [Abstract][Full Text] [Related]
14. A point mutation within CD45 exon A is the cause of variant CD45RA splicing in humans.
Zilch CF; Walker AM; Timón M; Goff LK; Wallace DL; Beverley PC
Eur J Immunol; 1998 Jan; 28(1):22-9. PubMed ID: 9485182
[TBL] [Abstract][Full Text] [Related]
15. CD45 function is regulated by an acidic 19-amino acid insert in domain II that serves as a binding and phosphoacceptor site for casein kinase 2.
Greer SF; Wang Y; Raman C; Justement LB
J Immunol; 2001 Jun; 166(12):7208-18. PubMed ID: 11390469
[TBL] [Abstract][Full Text] [Related]
16. Advances in the understanding and treatment of human severe combined immunodeficiency.
Buckley RH
Immunol Res; 2000; 22(2-3):237-51. PubMed ID: 11339359
[TBL] [Abstract][Full Text] [Related]
17. Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia.
Porcu M; Kleppe M; Gianfelici V; Geerdens E; De Keersmaecker K; Tartaglia M; Foà R; Soulier J; Cauwelier B; Uyttebroeck A; Macintyre E; Vandenberghe P; Asnafi V; Cools J
Blood; 2012 May; 119(19):4476-9. PubMed ID: 22438252
[TBL] [Abstract][Full Text] [Related]
18. Domain organization of the extracellular region of CD45.
Symons A; Willis AC; Barclay AN
Protein Eng; 1999 Oct; 12(10):885-92. PubMed ID: 10556250
[TBL] [Abstract][Full Text] [Related]
19. Development of intestinal intraepithelial lymphocytes, NK cells, and NK 1.1+ T cells in CD45-deficient mice.
Martin SM; Mehta IK; Yokoyama WM; Thomas ML; Lorenz RG
J Immunol; 2001 May; 166(10):6066-73. PubMed ID: 11342624
[TBL] [Abstract][Full Text] [Related]
20. Comparison of CD45 extracellular domain sequences from divergent vertebrate species suggests the conservation of three fibronectin type III domains.
Okumura M; Matthews RJ; Robb B; Litman GW; Bork P; Thomas ML
J Immunol; 1996 Aug; 157(4):1569-75. PubMed ID: 8759740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
